A Multinational, Multicentre, Randomized, Open, Parallel Group Study on the Efficacy and Safety of Bemiparin Sodium (LMWH) Compared to Enoxaparin Sodium (LMWH) in the Treatment of Acute Deep Vein Thrombosis (DVT)
Phase of Trial: Phase III
Latest Information Update: 06 Dec 2017
Price : $35 *
At a glance
- Drugs Bemiparin sodium (Primary) ; Enoxaparin sodium; Warfarin
- Indications Deep vein thrombosis; Thrombosis; Venous thromboembolism
- Focus Registrational; Therapeutic Use
- Sponsors Berlin Chemie
- 06 Dec 2017 Primary endpoint of percentage of patients with an improvement in thrombotic burden at visit 3 has been met, according to results published in the Clinical Drug Investigation.
- 06 Dec 2017 Results published in the Clinical Drug Investigation
- 03 Feb 2016 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.